MORE ARTICLES

Stay Connected!

Receive the latest updates in your inbox.

LATEST ARTICLES

Except in Florida, There’s Really No (High School) Debate

In much of the country, the state of America’s High school debate is not strong. Teachers and education professionals have become indoctrinated in an identity-obsessed, grievance-seeking body politic. But in Florida, students must thoroughly research debatable positions and are actually expected to engage with those who disagree.

Navigating Labor Shortages: The Role of Immigrants and the Potential of Schedule A

Milliken underscores the current unprecedented combination of low unemployment and high job openings, particularly in sectors like hospitality, healthcare, and education. She addresses the vital role immigrants play in the workforce, and advocates for leveraging Schedule A, a regulation that expedites the green card process for occupations facing high labor demand.

Hillsdale’s Dr. Kathleen O’Toole on K-12 Classical Education

Dr. O’Toole explores Hillsdale’s mission and its impact on K-12 education, delving into classical education, Greco-Roman ideals, Enlightenment principles, and the college’s efforts to enhance education. She discusses the challenges faced in exporting Hillsdale’s model to K-12 public schooling, critiques of American education, and the role of the liberal arts in fostering academic unity amidst societal divisions.

Supreme Oral Arguments: Do Gun Rights Rest on Responsible Behavior

Joe Selvaggi engages in a conversation with constitutional scholar Attorney Clark Neily to explore the oral arguments presented in the US Supreme Court case USA v Rahimi. The discussion delves into the intricate examination of behavioral history and the legal processes involved in restricting an individual from owning a firearm.

A nuclear winter is coming for biopharma

The life sciences sector in Massachusetts — which has been flying so high for so long — is about to experience a very hard landing. With the adoption of prescription drug price controls in the Inflation Reduction Act (IRA), drug research and development — the heart of the life sciences sector in Massachusetts — is about to experience a nuclear winter.